Highlights BeiGene, Ltd. Deutsche Boerse AG

Equities

49B

KYG1146Y1017

Market Closed - Deutsche Boerse AG Other stock markets 11:50:00 07/06/2024 am IST			5-day change	1st Jan Change
11 ^EUR	+2.80%		+1.85%	-11.29%

28/05	BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS First in Human Study	MT
28/05	BriaCell Therapeutics, BeiGene Partner to Test Combination of Companies' Cancer Treatments	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS First in Human Study	28/05	MT
BriaCell Therapeutics, BeiGene Partner to Test Combination of Companies' Cancer Treatments	28/05	MT
BriaCell Therapeutics Corp. Announces Clinical Supply Agreement with BeiGene, Ltd. for Bria-OTS First in Human Study	28/05	CI
BeiGene Says Studies Highlight Effectiveness, Safety of Lymphoma Drug Brukinsa	24/05	MT
BeiGene, Ltd. Announces New Analyses for BRUKINSA® (zanubrutinib) At ASCO Underscore Differentiated Clinical Profile for Treatment of CLL and SLL	24/05	CI
Glenmark Pharma Arm to Market Two Beigene Cancer Drugs in India	21/05	MT
Glenmark Specialty S.A. Announces an Exclusive Marketing and Distribution Agreement with BeiGene	21/05	CI
BeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024	15/05	CI
Beigene Q1 Loss Shrinks as Revenue Grows; Company's Shares Nearly 7% Up	09/05	MT
Sector Update: Health Care Stocks Lean Lower Pre-Bell Wednesday	08/05	MT
BeiGene's Q1 Loss Narrows as Revenue Rises	08/05	MT
Earnings Flash (BGNE) BEIGENE Reports Q1 Revenue $752M	08/05	MT
BeiGene, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05	CI
BeiGene, Ltd. Anticipates Opening of Biologics Manufacturing Facility and Clinical R&D Center at the Princeton West Innovation Campus in Hopewell, New Jersey, in July 2024	08/05	CI
Amgen Posts Higher 1Q Revenue, Swings to Loss	03/05	DJ
BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer; Shares Rise	23/04	MT
BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer	23/04	MT
BeiGene, Ltd. Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer	23/04	CI
BeiGene Opens New Factory in Guangzhou for Antibody-Drug Conjugates	10/04	MT
Beigene Shrinks Loss by 56% in 2023	29/03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights BeiGene, Ltd. Deutsche Boerse AG

Equities

49B

KYG1146Y1017

Highlights

Filters